Cryo Cell International Inc 's Cash & cash equivalent grew by 9.03 % in the Q2 2026 sequentially, while Current Liabilities decreased, this led to improvement in Cryo Cell International Inc 's Quick Ratio to 0.2, Quick Ratio remained below Cryo cell International Inc average.

Within Healthcare Facilities industry 30 other companies have achieved higher Quick Ratio than Cryo Cell International Inc in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 3570, from total ranking in the first quarter 2026 at 4368.

Explain Quick Ratio?
How much Cash & cash equivalents CCEL�s has?
What are CCEL�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CCEL Quick Ratio	(May 31 2026) Q2	(Feb 28 2026) Q1	(Nov 30 2025) Q4	(Aug 31 2025) Q3	(May 31 2025) Q2
Y / Y Current Liabilities Change	-26.77 %	-18.22 %	-8.36 %	5.91 %	11.85 %
Y / Y Cash & cash equivalent Change	-28.64 %	-16.65 %	-5.72 %	51.46 %	189.68 %
Quick Ratio MRQ	0.2	0.16	0.17	0.17	0.2
CCEL's Total Ranking	# 3570	# 4368	# 4112	# 4077	# 4274
Seq. Current Liabilities Change	-10.32 %	-10.25 %	7.27 %	-15.18 %	0.14 %
Seq. Cash & cash equivalent Change	9.03 %	-12.01 %	2.32 %	-27.3 %	27.35 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Healthcare Facilities Industry	# 31
Healthcare Sector	# 824
Overall Market	# 3386

Quick Ratio Statistics
High	Average	Low
1.5	0.49	0.05
(Nov 30 2020)

Financial Statements
Cryo Cell International Inc 's Current Liabilities	$ 16 Millions	Visit CCEL's Balance sheet
Cryo Cell International Inc 's Cash & cash equivalent	$ 3 Millions	Visit CCEL's Balance sheet
Source of CCEL's Sales		Visit CCEL's Sales by Geography

Cumulative Cryo Cell International Inc 's Quick Ratio

CCEL's Quick Ratio for the trailling 12 Months

CCEL Quick Ratio	(May 31 2026) 12 Months	(Feb 28 2026) 12 Months	(Nov 30 2025) 12 Months	(Aug 31 2025) 12 Months	(May 31 2025) 12 Months
Y / Y Current Liabilities TTM Growth	-12.8 %	-3.03 %	4.98 %	8.33 %	5.43 %
Y / Y Cash & cash equivalent TTM Growth	-7.05 %	30.25 %	77.42 %	160.45 %	188.13 %
Quick Ratio TTM	0.17	0.18	0.18	0.18	0.16
Total Ranking TTM	# 3959	# 4598	# 3503	# 3558	# 3561
Seq. Current Liabilities TTM Growth	-7.49 %	-4.84 %	-2.16 %	1.25 %	2.87 %
Seq. Cash & cash equivalent TTM Growth	-9.16 %	-4.02 %	-1.37 %	8.09 %	27.29 %

Quick ratio ranking by company, industry and sector >> Back to CCEL Financial Strength Comparisons >> Go to Compare CCEL Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in CCEL's Current Liabilities to $15.93 millions, cumulative Quick Ratio to 0.17 below the CCEL average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Healthcare Facilities industry 40 other companies have achieved higher Quick Ratio than Cryo Cell International Inc . While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2026 at 3227.

Explain Quick Ratio?
How much Cash & cash equivalents CCEL�s has?
What are CCEL�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Healthcare Facilities Industry	# 41
Healthcare Sector	# 914
Within the Market	# 3570

trailing twelve months Quick Ratio Statistics
High	Average	Low
0.67	0.33	0.01
(Aug 31 2012)		(Nov 30 2025)

Companies with similar Quick Ratio in the quarter ending May 31 2026, within Healthcare Facilities Industry	Quick Ratio	May 31 2026 MRQ Cash & cash equivalent	May 31 2026 MRQ Current Liabilities
Airsculpt Technologies Inc	0.54	$ 18.824 Millions	$ 34.949 Millions
Lifemd Inc	0.54	$ 25.385 Millions	$ 47.386 Millions
Concentra Group Holdings Parent Inc	0.43	$ 158.038 Millions	$ 367.939 Millions
Tenet Healthcare Corp	0.39	$ 2,170.000 Millions	$ 5,567.000 Millions
Sonida Senior Living Inc	0.39	$ 48.709 Millions	$ 125.363 Millions
Surgery Partners Inc	0.37	$ 216.700 Millions	$ 578.500 Millions
Ensign Group Inc	0.36	$ 320.844 Millions	$ 884.799 Millions
Brightspring Health Services Inc	0.35	$ 550.381 Millions	$ 1,555.633 Millions
Pacs Group Inc	0.28	$ 299.172 Millions	$ 1,055.058 Millions
Encompass Health Corporation	0.27	$ 234.700 Millions	$ 873.400 Millions
Davita Inc	0.25	$ 727.242 Millions	$ 2,855.432 Millions
Aveanna Healthcare Holdings Inc	0.24	$ 97.196 Millions	$ 411.324 Millions
Viemed Healthcare Inc	0.22	$ 10.680 Millions	$ 47.893 Millions
Cryo cell International Inc	0.20	$ 3.162 Millions	$ 15.930 Millions
Mangoceuticals Inc	0.18	$ 0.246 Millions	$ 1.398 Millions
Chemed Corporation	0.13	$ 40.222 Millions	$ 319.846 Millions
Agilon Health Inc	0.10	$ 133.084 Millions	$ 1,312.349 Millions
Community Health Systems Inc	0.07	$ 149.000 Millions	$ 2,016.000 Millions
Cardiff Lexington Corporation	0.06	$ 0.218 Millions	$ 3.791 Millions

Date modified: 2026-09-19T05:06:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.